Security key
51654W101
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)
CUSIP: 51654W101
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 2,069,248
- Total 13F value
- $2,834,887
- Share change
- -157,557
- SEC-reported price per share
- $1.37
- Number of holders
- 32
- Value change
- -$318,385
- Number of buys
- 11
- Number of sells
- 11
- Shares outstanding
- 12,752,344
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q1 2026
Institutions
32
Top holders
10
LTRN full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Lantern Pharma Inc. SEC filings
Lantern Pharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 51654W101
Recent filing periods:
Ownership snapshot
Top reported holders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Thomas A. Satterfield Jr.
Disclosed value leader
Aaron G.l. Fletcher
Comparable rows
15/15
Latest evidence
30 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 5.1%
13D/G row: Thomas A. Satterfield Jr.
Showing 1-6 of 15 holder rows.
Quick read
Thomas A. Satterfield Jr. leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Thomas A. Satterfield Jr.
5.1%
Aaron G.l. Fletcher
8.4%
Leslie W. Kreis
8.4%
BIOS Capital Management, LP
7.9%
VANGUARD GROUP INC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Thomas A. Satterfield Jr. |
13D/G
|
5.1%
|
$1,727,100
570,000 shares
|
$0 | 30 Mar 2026 |
| Aaron G.l. Fletcher |
3/4/5
10%+ Owner
|
8.4%
|
$3,344,781
1,075,952 shares
|
-$331,871 | 13 Jun 2025 |
| Leslie W. Kreis |
3/4/5
10%+ Owner
|
8.4%
|
$3,344,781
1,075,952 shares
|
-$331,871 | 13 Jun 2025 |
| BIOS Capital Management, LP |
13F
Company
|
7.9%
|
$3,058,806
1,009,507 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3%
|
$1,163,644
384,041 shares
|
— | 31 Dec 2025 |
| CM Management, LLC |
13F
Company
|
1.8%
|
$681,750
225,000 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
32
Shares
2,069,248
Rows available
32
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
33
Q1 2026 holders
32
Holder diff
-1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend